On June 30, 2025, the United States Attorney Craig H. Missakian announced criminal charges against five individuals accused of defrauding Medicare and other federal health care programs, as well as illegally diverting drugs. These charges are part of the Department of Justice’s 2025 National Health Care Fraud Takedown.
The cases involve a range of schemes including false claims for medical equipment, fraudulent billing to federally funded health insurance programs, and illegal drug diversion. U.S. Attorney Missakian emphasized the impact on vulnerable populations and taxpayers, stating: “Fraud and abuse in our health care system all too often result in harm to the elderly and sick and a loss to the American taxpayer.”
Attorney General Pamela Bondi also commented on the initiative: “This record-setting Health Care Fraud Takedown delivers justice to criminal actors who prey upon our most vulnerable citizens.”
In total, 324 defendants face charges related to over $14.6 billion in alleged false billings and more than 15 million pills of illegally diverted controlled substances. The government has seized over $245 million in cash, luxury vehicles, and other assets connected with these activities.
Among those charged is Vincent Thayer from San Jose, California. He faces accusations involving wire fraud, health care fraud, and identity theft linked to a $68 million scheme through his company My Community Testing.
Sevendik Huseynov from Sunnyvale, California is charged with health care fraud for allegedly submitting fraudulent claims for durable medical equipment through his company Vonyes Inc., totaling over $137 million.
Clinton Johnson Christian from Fairfield, California is accused of tampering with consumer products by diverting controlled substances for personal use.
Dr. Yasmin Pirani from British Columbia is charged with participating in a telemedicine fraud scheme valued at $35.2 million by signing unnecessary prescriptions without proper patient interaction.
Patrick Omeife from Ghana faces money laundering charges related to laundering funds intended for COVID-19 relief through fraudulent means.
FBI Special Agent Sanjay Virmani remarked on the significance of combating healthcare fraud: “Healthcare fraud is not a victimless crime… it undermines public trust.” Robert Iwanicki from FDA Office of Criminal Investigations highlighted their commitment to prosecuting threats to consumer safety.
These cases are being prosecuted by various U.S. Attorneys’ Offices nationwide with assistance from multiple law enforcement agencies including the FBI and FDA Office of Criminal Investigations.
All defendants are presumed innocent until proven guilty beyond a reasonable doubt in court.
